(R)-4-isopropyloxazolidine-2,5-dione, 98%, 1g

6-BROMO-7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 250mg

1-[3-(6-bromo-2H-1,3-benzoxazin-3(4H)-yl)phenyl]ethanone, 95.0%, 1g

N-benzyl-4-methyl-1,3-benzothiazol-2-amine, 95.0%, 250mg

4-ethyl-5-[(4-fluorophenoxy)methyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

Methyl 5-Chlorothiophene-2-carboxylate>98.0%(GC)5g

(3R,6R,7aS)-6-Bromo-3-phenyltetrahydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one, 95%, 500mg

(3S)-1-(3-chloro-2-methylbenzenesulfonyl)-N-cyclohexylpiperidine-3-carboxamide, 95.0%, 250mg

3-(4-Fluorophenoxy)propionic acid, 97.0%, 5g

4,4'-Diamino-[1,1'-biphenyl]-3,3'-dicarboxylic acid, 97%, 1g

Colonna capillare per GC ROTI®Cap-5, 25 m, 0.25 mm, 1.00 µm, 1 Pezzo(i)

Vinyltrimethoxysilane>98.0%(GC)100mL

4-[2-(Trifluoromethyl)phenyl]oxane-4-carboxylic acid, 1g